Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154448 · ClinicalTrials.gov registry record · NA
Double Arm Pivotal Study to Evaluate the Neurolyser XR for the Treatment of Chronic Low Back Pain
A NA study of Facet Syndrome of Lumbar Spine, sponsored by FUSMobile.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 10
- Study locations
NCT05154448 is a NA study of Facet Syndrome of Lumbar Spine that has completed, run by FUSMobile. The registered enrollment target is 90 participants. The trial reports 10 study locations across 6 states.
The verdict
NCT05154448, a NA study of Facet Syndrome of Lumbar Spine, has completed, sponsored by FUSMobile.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 10
- Study locations
Study Summary
Double arm pivotal study to evaluate the Neurolyser XR as a non-invasive treatment of axial chronic low back pain
Conditions Studied
Interventions
- OTHER Sham procedure
- DEVICE Non-Invasive Thermal Ablation of the Medial Branch Nerves (Neurolyser XR)
Study Locations (10)
Georgia
- Emory - Atlanta
- The Physicians Spine and Rehabilitation Specialist of GA - Atlanta
- Charlie Norwood VA Medical Center - Augusta
Florida
- Mayo University Jacksonville - Jacksonville
- Univ of Miami Rehabilitation Medicine - Miami
Virginia
- University of Virginia Pain Management Center - Charlottesville
- Gershon Pain Specialists - Virginia Beach
Connecticut
- Stamford Hospital - Stamford
New York
- Ainsworth Institute of Pain Management - New York
North Carolina
- Center for Clinical Research - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2024-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154448
The ClinicalTrials.gov registry entry for NCT05154448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FUSMobile, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facet Syndrome of Lumbar Spine appearing as the primary indexed condition, and to 2 interventions - of which Sham procedure is the first listed.
NCT05154448 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Georgia, Florida, Virginia.
Frequently Asked Questions
What is clinical trial NCT05154448 about?
NCT05154448 is a clinical study titled "Double Arm Pivotal Study to Evaluate the Neurolyser XR for the Treatment of Chronic Low Back Pain". Double arm pivotal study to evaluate the Neurolyser XR as a non-invasive treatment of axial chronic low back pain
What is the current status of trial NCT05154448?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-05-16. Estimated completion is 2024-04-16.
What conditions does trial NCT05154448 study?
This clinical trial studies the following conditions: Facet Syndrome of Lumbar Spine.
What interventions are being tested in trial NCT05154448?
The interventions under investigation include: Sham procedure (OTHER), Non-Invasive Thermal Ablation of the Medial Branch Nerves (Neurolyser XR) (DEVICE).
Who is sponsoring clinical trial NCT05154448?
This trial is sponsored by FUSMobile, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05154448 being conducted?
This trial has 10 study locations across Connecticut, Florida, Georgia, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.